Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported double-digit growth in revenue and adjusted earnings for the fourth quarter of fiscal 2025, which also exceeded estimates. The stock rallied soon after the announcement on Thursday. The medical device maker said that for fiscal 2026, it expects a slower growth in Worldwide da Vinci procedures.
On an adjusted basis, fourth-quarter earnings rose to $2.53 per share from $2.21 per share in the comparable period last year, exceeding expectations. Unadjusted net income attributable to the company was $795 million or $2.21 per share in Q4, compared to $686 million or $1.88 per share in the same period of FY24.
Intuitive reported net revenues of $2.87 billion for the December quarter, which is up 19% from the year-ago period and above analysts’ consensus estimates. Worldwide da Vinci procedures grew approximately 18% in Q4 from the prior-year quarter.
The management expects worldwide da Vinci procedures to grow between 13% and 15% in fiscal 2026, compared to 18% in FY25. On an adjusted basis, full-year gross profit margin is expected to be in the range of 67% to 68% of total revenue, vs. 67.6% last year. It is looking for operating expense growth of 11-15% in 2026, on an adjusted basis.